{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:09:25Z","timestamp":1773288565582,"version":"3.50.1"},"reference-count":40,"publisher":"Begell House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Hepatocellular carcinoma (HCC) is one of the most malignant solid tumors worldwide. Long non-coding RNAs (lncRNAs) are the key factor in the pathogenesis of HCC. This study aimed to investigate the roles of lncRNA FTX transcript, XIST regulator (FTX) in HCC. mRNA levels were detected using RT-qPCR. Protein expression was determined using Western blot. cellular functions were determined using Cell Counting Kit (CCK)-8 and propidium iodide (PI) staining assays. RNA fluorescent &lt;i&gt;in situ&lt;\/i&gt; hybridization (FISH) assay was conducted to analyze the location of lncRNA FTX and DNMT1. RNA pulldown, RNA immunoprecipitation (RIP), and chromatin-immunoprecipitation (ChIP) assays were used to ascertain the involved mechanisms. We found that FTX was downregulated in HCC patients, which was associated with poor prognosis. Moreover, DNA methyltransferase 1 (DNMT1)-mediated methylation of FTX promoter inhibited its expression. Interestingly, overexpression of FTX promoted the ferroptosis of HCC cells. FTX sponged miR-374b-3p to upregulate transferrin receptor (TFRC) expression. However, downregulation of miR-374b-3p or overexpression of TFRC alleviated the effects of FTX knockdown and promoted the survival of HCC cells. In conclusion, DNMT1-dependent DNA methylation of FTX promotes the development of HCC through regulating miR-374b-3p\/TFRC axis. Therefore, DNMT1\/FTX\/miR-374b-3p\/TFRC axis may be a potential target for HCC.\n<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2024054376","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:42:23Z","timestamp":1720190543000},"page":"1-13","source":"Crossref","is-referenced-by-count":3,"title":["DNMT1-Dependent DNA Methylation of lncRNA FTX Inhibits the Ferroptosis of Hepatocellular Carcinoma"],"prefix":"10.1615","volume":"35","author":[{"given":"Sunfu","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaodan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Su T, Zhang N, Wang T, Zeng J, Li W, Han L, Yang M. Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis. Cancer Res. 2023;83:4080-94.","DOI":"10.1158\/0008-5472.CAN-23-0544"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, Xu Z, Yang Y, Weng Q, Zhao Z, Chen M, Ji J. Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response. Adv Sci. 2023;10:e2203973.","DOI":"10.1002\/advs.202203973"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, Gores G, Villanueva A. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3:386-401.","DOI":"10.1038\/s43018-022-00357-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","DOI":"10.1038\/s41572-020-00240-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Wang Z, Qin H, Liu S, Sheng J, Zhang X. Precision diagnosis of hepatocellular carcinoma. Chin Med J. 2023;136:1155-65.","DOI":"10.1097\/CM9.0000000000002641"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82:2252-66.","DOI":"10.1016\/j.molcel.2022.05.027"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 2021;41:109-20.","DOI":"10.1002\/cac2.12108"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 2022;23:389-406.","DOI":"10.1038\/s41580-021-00447-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Sheng JQ, Wang MR, Fang D, Liu L, Huang WJ, Tian DA, He XX, Li PY. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomed Pharmacother. 2021;133:111023.","DOI":"10.1016\/j.biopha.2020.111023"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Liu F, Yuan JH, Huang JF, Yang F, Wang TT, Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, Zhou WP, Sun SH. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Oncogene. 2016;35:5422-34.","DOI":"10.1038\/onc.2016.80"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Wu H, Zhong Z, Wang A, Yuan C, Ning K, Hu H, Wang C, Yin X. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1\/M2 polarization of Kupffer cells. Cancer Cell Int. 2020;20:266.","DOI":"10.1186\/s12935-020-01354-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215-27.","DOI":"10.1016\/j.molcel.2022.03.022"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381-396.","DOI":"10.1038\/s41568-022-00459-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599-620.","DOI":"10.1007\/s13238-020-00789-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B. Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","DOI":"10.1186\/s13045-019-0720-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Yang M, Wu X, Hu J, Wang Y, Wang Y, Zhang L, Huang W, Wang X, Li N, Liao L, Chen M, Xiao N, Dai Y, Liang H, Huang W, Yuan L, Pan H, Li L, Chen L, Liu L, Liang L, Guan J. COMMD10 inhibits HIF1alpha\/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. J Hepatol. 2022;76:1138-50.","DOI":"10.1016\/j.jhep.2022.01.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Zhang T, Sun L, Hao Y, Suo C, Shen S, Wei H, Ma W, Zhang P, Wang T, Gu X, Li ST, Chen Z, Yan R, Zhang Y, Cai Y, Zhou R, Jia W, Huang F, Gao P, Zhang H. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat Cancer. 2022;3:75-89.","DOI":"10.1038\/s43018-021-00299-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Yang J, Qu T, Li Y, Ma J, Yu H. Biological role of long non-coding RNA FTX in cancer progression. Biomed Pharmacother. 2022;153:113446.","DOI":"10.1016\/j.biopha.2022.113446"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Li S, Zhang Q, Liu W, Zhao C. Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p. BMC Cancer. 2021;21:290.","DOI":"10.1186\/s12885-021-07975-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Wang P, Zhang Y, Wang W, Jiang H. Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer. Oncol Lett. 2021;22:672.","DOI":"10.3892\/ol.2021.12933"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Huang W, Li H, Yu Q, Xiao W, Wang DO. LncRNA-mediated DNA methylation: An emerging mechanism in cancer and beyond. J Exp Clin Cancer Res. 2022;41:100.","DOI":"10.1186\/s13046-022-02319-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42:88-116.","DOI":"10.1002\/cac2.12250"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65:625-39.","DOI":"10.1042\/EBC20200032"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sadeghi M, Bahrami A, Hasankhani A, Kioumarsi H, Nouralizadeh R, Abdulkareem SA, Ghafouri F, Barkema HW. lncRNA-miRNA-mRNA ceRNA network involved in sheep prolificacy: An integrated approach. Genes. 2022;13(8):1295.","DOI":"10.3390\/genes13081295"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Huang Y, Wang S, Ke A, Guo K. Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochim Biophys Acta Rev Cancer. 2023;1878:188848.","DOI":"10.1016\/j.bbcan.2022.188848"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X and Wu C. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110.","DOI":"10.1016\/j.biomaterials.2021.121110"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","DOI":"10.1038\/s41392-024-01769-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, Sun G, Sun G, Liu L, Yu H, Tang W, Wang X. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.","DOI":"10.1016\/j.redox.2022.102463"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30:478-90.","DOI":"10.1016\/j.tcb.2020.02.009"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188394.","DOI":"10.1016\/j.bbcan.2020.188394"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8:449.","DOI":"10.1038\/s41392-023-01720-0"},{"key":"33","unstructured":"Zhang F, Wang XS, Tang B, Li PA, Wen Y, Yu PW. Long non-coding RNA FTX promotes gastric cancer progression by targeting miR-215. Eur Rev Med Pharmacol Sci. 2020;24:3037-48."},{"key":"34","doi-asserted-by":"crossref","unstructured":"Jin S, He J, Zhou Y, Wu D, Li J, Gao W. LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis. J Cell Mol Med. 2020;24:4839-49.","DOI":"10.1111\/jcmm.15163"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Huang S, Zhang P, Yin N, Xu Z, Liu X, Wu A, Zhang X, Li Z, Zhang Z, Zhong T, Liu L, Shi Y, Dong J. Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization. iScience. 2024;27: 109270.","DOI":"10.1016\/j.isci.2024.109270"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Zhang Y, Luo M, Cui X, O'Connell D, Yang Y. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a ceRNA. Cell Death Differ. 2022;29:1850-63.","DOI":"10.1038\/s41418-022-00970-9"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Zhong F, Wang Y. YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p\/CPEB1. Biochem Biophys Res Commun. 2023;679:98-109.","DOI":"10.1016\/j.bbrc.2023.08.056"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Chen GQ, Liao ZM, Liu J, Li F, Huang D, Zhou YD. LncRNA FTX promotes colorectal cancer cells migration and invasion by miRNA-590-5p\/RBPJ axis. Biochem Genet. 2021;59:560-73.","DOI":"10.1007\/s10528-020-10017-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Pei Z, Qin Y, Fu X, Yang F, Huo F, Liang X, Wang S, Cui H, Lin P, Zhou G, Yan J, Wu J, Chen ZN, Zhu P. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. Redox Biol. 2022;57:102509.","DOI":"10.1016\/j.redox.2022.102509"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Lu Y, Yang Q, Su Y, Ji Y, Li G, Yang X, Xu L, Lu Z, Dong J, Wu Y, Bei JX, Pan C, Gu X, Li B. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis. 2021;12:511.","DOI":"10.1038\/s41419-021-03790-w"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Zhu G, Murshed A, Li H, Ma J, Zhen N, Ding M, Zhu J, Mao S, Tang X, Liu L, Sun F, Jin L, Pan Q. O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP\/TFRC pathway in liver cancer. Cell Death Discov. 2021;7:83.","DOI":"10.1038\/s41420-021-00468-2"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/2cf5b9f922521208\/CRE-54376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:37:00Z","timestamp":1733463420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,0090223e275b4021,2cf5b9f922521208.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2024054376","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}